KRISTIN LEONARD: Open Payments
NPI 1881924124 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 44 payments from 8 companies in 2025. Trend: 2023 $149 · 2024 $166 · 2025 $976
Food & beverage: $876Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $412 |
| AstraZeneca Pharmaceuticals LP | 8 | $250 |
| GlaxoSmithKline, LLC. | 15 | $140 |
| Genentech USA, Inc. | 3 | $91 |
| GENZYME CORPORATION | 1 | $24 |
| LEO Pharma Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| CSL Behring | 1 | $15 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, AIRSUPRA, Xolair, ANZUPGO, CUVITRU, Andembry.
Industry payments across CA — which companies pay providers there.
